LNPs & Beyond: Opportunities in RNA Delivery

LNPs & Beyond: Opportunities In RNA Delivery 10/6/2022
The rapid development, scale-up, and successful commercialization of mRNA vaccines served as a great case study on the importance of mRNA/RNA therapeutics. For those striving to develop next-gen RNA therapeutics, achieving more specifically targeted non-viral delivery is a large hurdle to broadening their applicability, durability, and effectiveness.

This website uses cookies to ensure you get the best experience on our website. Learn more